Overview

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Status:
Recruiting

Trial end date:
2025-07-01

Target enrollment:

Participant gender:

Summary

A multicenter, open phase I clinical study to evaluate the safety, tolerance and pharmacokinetics of BAT8007 for injection in patients with advanced solid tumors.

Phase:

Phase 1

Details

Lead Sponsor:

Bio-Thera Solutions

Collaborator:

Zhejiang Tumor Hospital

Treatments:

Exatecan